scholarly article | Q13442814 |
P2093 | author name string | G Liu | |
S Ono | |||
M R Dana | |||
A M Keane-Myers | |||
D Miyazaki | |||
I Dekaris | |||
P433 | issue | 12 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | eye disease | Q3041498 |
P304 | page(s) | 3041-3046 | |
P577 | publication date | 1999-11-01 | |
P1433 | published in | Investigative Ophthalmology Visual Science | Q6060707 |
P1476 | title | Prevention of allergic eye disease by treatment with IL-1 receptor antagonist | |
P478 | volume | 40 |
Q82485365 | A specific CCR3 chemokine receptor antagonist inhibits both early and late phase allergic inflammation in the conjunctiva |
Q41837279 | Conjunctival mast cell as a mediator of eosinophilic response in ocular allergy |
Q35221349 | Effects of interleukin-1 receptor antagonist on tumor stroma in experimental uveal melanoma |
Q24557550 | Macrophage inflammatory protein-1alpha as a costimulatory signal for mast cell-mediated immediate hypersensitivity reactions |
Q34529798 | New twists to an old story: novel concepts in the pathogenesis of allergic eye disease |
Q38904210 | Ocular Manifestations of Inherited Phospholipase-Cγ2-Associated Antibody Deficiency and Immune Dysregulation |
Q34730735 | Ocular allergy guidelines: a practical treatment algorithm |
Q55299223 | Phage Therapy: Beyond Antibacterial Action. |
Q47550004 | Phage therapy in allergic disorders? |
Q37295510 | Suppression of experimental uveitis by a recombinant adeno-associated virus vector encoding interleukin-1 receptor antagonist |
Q47094978 | The importance of pegaptanib sodium treatment for patients with vascular active vitreoretinopathy |
Q34561837 | The pathogenesis of allergic conjunctivitis |
Q34206399 | Topical interleukin 1 receptor antagonist for treatment of dry eye disease: a randomized clinical trial. |
Q81606847 | [Ocular allergies] |
Search more.